Early participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II

BACKGROUND: Anastrozole reduces breast cancer risk in women at high risk, but implementing preventive therapy in clinical practice is difficult. Here, we evaluate adherence to anastrozole in the International Breast Cancer Intervention Study (IBIS)-II prevention and ductal carcinoma in situ (DCIS) t...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Oncol
Auteurs principaux: Sestak, I, Smith, S G, Howell, A, Forbes, J F, Cuzick, J
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2018
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5834118/
https://ncbi.nlm.nih.gov/pubmed/29126161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdx713
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires